Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats

Chang Gyu Park, Frans H H Leenen

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

To investigate whether brain AT1 receptor stimulation contributes as a hypertensive mechanism to deoxycorticosterone acetate (DOCA)-salt hypertension, losartan (1 mg/4μL) or artificial cerebrospinal fluid (aCSF) was injected into the lateral cerebral ventricle in conscious control uninephrectomized Wistar rats or rats with DOCA-salt for 2 or 4 weeks, and mean arterial pressure (MAP) and heart rates (HR) were recorded. In rats with DOCA-salt treatment, resting MAP increased to 144±6 mmHg after 2 weeks and to 170±5 mmHg after 4 weeks versus 115-120 mmHg in controls. In rats with 2 week DOCA-salt treatment, MAP started declining at 4 hr after intracerebroventricular (icv) injection of losartan, and significant decreases in MAP were found at 18 and 24 hr. In rats with 4 week DOCA-salt treatment, MAP was significantly decreased at 4, 18 and 24 hr. In both groups MAP decreased to that of control rats. In control rats, icv losartan had no effect on MAP and HR. Icv aCSF did not significantly change MAP and HR in either DOCA-salt hypertensive rats or control rats. Normalization of MAP after icv administration of the AT1 receptor antagonist suggests a significant role for brain AT1 receptor stimulation in the development and maintenance of hypertension in the DOCA-salt hypertensive rat model.

Original languageEnglish
Pages (from-to)553-557
Number of pages5
JournalJournal of Korean Medical Science
Volume16
Issue number5
Publication statusPublished - 2001 Oct 1

Fingerprint

Desoxycorticosterone
Losartan
Arterial Pressure
Salts
Hypertension
Acetates
Heart Rate
Cerebrospinal Fluid
Cerebral Ventricles
Lateral Ventricles
Brain
Wistar Rats
Therapeutics
Maintenance
Injections

Keywords

  • Angiotensin II
  • Brain AT Receptor
  • Deoxycorticosterone, Hypertension
  • Losartan

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats. / Park, Chang Gyu; Leenen, Frans H H.

In: Journal of Korean Medical Science, Vol. 16, No. 5, 01.10.2001, p. 553-557.

Research output: Contribution to journalArticle

@article{0ee8523c871d4f30a208b47e073b258d,
title = "Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats",
abstract = "To investigate whether brain AT1 receptor stimulation contributes as a hypertensive mechanism to deoxycorticosterone acetate (DOCA)-salt hypertension, losartan (1 mg/4μL) or artificial cerebrospinal fluid (aCSF) was injected into the lateral cerebral ventricle in conscious control uninephrectomized Wistar rats or rats with DOCA-salt for 2 or 4 weeks, and mean arterial pressure (MAP) and heart rates (HR) were recorded. In rats with DOCA-salt treatment, resting MAP increased to 144±6 mmHg after 2 weeks and to 170±5 mmHg after 4 weeks versus 115-120 mmHg in controls. In rats with 2 week DOCA-salt treatment, MAP started declining at 4 hr after intracerebroventricular (icv) injection of losartan, and significant decreases in MAP were found at 18 and 24 hr. In rats with 4 week DOCA-salt treatment, MAP was significantly decreased at 4, 18 and 24 hr. In both groups MAP decreased to that of control rats. In control rats, icv losartan had no effect on MAP and HR. Icv aCSF did not significantly change MAP and HR in either DOCA-salt hypertensive rats or control rats. Normalization of MAP after icv administration of the AT1 receptor antagonist suggests a significant role for brain AT1 receptor stimulation in the development and maintenance of hypertension in the DOCA-salt hypertensive rat model.",
keywords = "Angiotensin II, Brain AT Receptor, Deoxycorticosterone, Hypertension, Losartan",
author = "Park, {Chang Gyu} and Leenen, {Frans H H}",
year = "2001",
month = "10",
day = "1",
language = "English",
volume = "16",
pages = "553--557",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "5",

}

TY - JOUR

T1 - Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats

AU - Park, Chang Gyu

AU - Leenen, Frans H H

PY - 2001/10/1

Y1 - 2001/10/1

N2 - To investigate whether brain AT1 receptor stimulation contributes as a hypertensive mechanism to deoxycorticosterone acetate (DOCA)-salt hypertension, losartan (1 mg/4μL) or artificial cerebrospinal fluid (aCSF) was injected into the lateral cerebral ventricle in conscious control uninephrectomized Wistar rats or rats with DOCA-salt for 2 or 4 weeks, and mean arterial pressure (MAP) and heart rates (HR) were recorded. In rats with DOCA-salt treatment, resting MAP increased to 144±6 mmHg after 2 weeks and to 170±5 mmHg after 4 weeks versus 115-120 mmHg in controls. In rats with 2 week DOCA-salt treatment, MAP started declining at 4 hr after intracerebroventricular (icv) injection of losartan, and significant decreases in MAP were found at 18 and 24 hr. In rats with 4 week DOCA-salt treatment, MAP was significantly decreased at 4, 18 and 24 hr. In both groups MAP decreased to that of control rats. In control rats, icv losartan had no effect on MAP and HR. Icv aCSF did not significantly change MAP and HR in either DOCA-salt hypertensive rats or control rats. Normalization of MAP after icv administration of the AT1 receptor antagonist suggests a significant role for brain AT1 receptor stimulation in the development and maintenance of hypertension in the DOCA-salt hypertensive rat model.

AB - To investigate whether brain AT1 receptor stimulation contributes as a hypertensive mechanism to deoxycorticosterone acetate (DOCA)-salt hypertension, losartan (1 mg/4μL) or artificial cerebrospinal fluid (aCSF) was injected into the lateral cerebral ventricle in conscious control uninephrectomized Wistar rats or rats with DOCA-salt for 2 or 4 weeks, and mean arterial pressure (MAP) and heart rates (HR) were recorded. In rats with DOCA-salt treatment, resting MAP increased to 144±6 mmHg after 2 weeks and to 170±5 mmHg after 4 weeks versus 115-120 mmHg in controls. In rats with 2 week DOCA-salt treatment, MAP started declining at 4 hr after intracerebroventricular (icv) injection of losartan, and significant decreases in MAP were found at 18 and 24 hr. In rats with 4 week DOCA-salt treatment, MAP was significantly decreased at 4, 18 and 24 hr. In both groups MAP decreased to that of control rats. In control rats, icv losartan had no effect on MAP and HR. Icv aCSF did not significantly change MAP and HR in either DOCA-salt hypertensive rats or control rats. Normalization of MAP after icv administration of the AT1 receptor antagonist suggests a significant role for brain AT1 receptor stimulation in the development and maintenance of hypertension in the DOCA-salt hypertensive rat model.

KW - Angiotensin II

KW - Brain AT Receptor

KW - Deoxycorticosterone, Hypertension

KW - Losartan

UR - http://www.scopus.com/inward/record.url?scp=0035486903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035486903&partnerID=8YFLogxK

M3 - Article

C2 - 11641522

AN - SCOPUS:0035486903

VL - 16

SP - 553

EP - 557

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 5

ER -